Draupnir Bio Logo.JPG
Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins
17 juil. 2024 07h00 HE | Draupnir Bio
Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare and EIFO join existing investors, Gilde Healthcare...
U.S. Believers Favor International Action on Climate Change, Nuclear Risk: UMD Poll
07 déc. 2011 10h32 HE | University of Maryland, College Park
COLLEGE PARK, Md., Dec. 7, 2011 (GLOBE NEWSWIRE) -- A majority of Americans professing belief in God favor cooperative international efforts to combat climate change and the spread of nuclear weapons...